Literature DB >> 29370724

Do immune checkpoint inhibitors increase sensitivity to salvage chemotherapy?

Khalil Saleh1, Nadine Khalifeh-Saleh1, Hampig Raphaël Kourie1, Fadi Nasr1, Georges Chahine1.   

Abstract

Keywords:  checkpoint inhibitors; salvage chemotherapy; sensitivity

Mesh：

Substances：

Year:  2018        PMID： 29370724     DOI： 10.2217/imt-2017-0153

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  2 in total

Review 1.  [Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the 2019 ASCO Meeting].

Authors:  H B Zech; S Laban; P Schafhausen; L Bussmann; C Betz; C-J Busch
Journal:  HNO       Date:  2019-12       Impact factor: 1.284

2.  Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: real-world data from a European cohort.

Authors:  Giulio Metro; Alfredo Addeo; Diego Signorelli; Alessio Gili; Panagiota Economopoulou; Fausto Roila; Giuseppe Banna; Alessandro De Toma; Juliana Rey Cobo; Andrea Camerini; Athina Christopoulou; Giuseppe Lo Russo; Marco Banini; Domenico Galetta; Beatriz Jimenez; Ana Collazo-Lorduy; Antonio Calles; Panagiotis Baxevanos; Helena Linardou; Paris Kosmidis; Marina C Garassino; Giannis Mountzios
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.